Evidence map›Paper›PMID 34167379›Full record

ArticleChronic respiratory disease

An expert review on breaking barriers in severe asthma in Brazil: Time to act.

Paulo Márcio Pitrez, Pedro Giavina-Bianchi, José Ângelo Rizzo, Adelmir Souza-Machado, Guilherme Freire Garcia, Marcia Margaret Menezes Pizzichini

Open access · goldAbstract read
In one paragraph

Article in Chronic respiratory disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Bronchodilator response assessment through impulse oscillometry system and spirometry in children and adolescents with cystic fibrosis.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2024
    Article
  2. The challenges of asthma care in low- and middle-income countries: what's next?Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Paulo Márcio PitrezPediatric Pulmonology Division, 156417Hospital Moinhos de Vento, Porto Alegre, Brazil.ORCID 0000-0001-7319-1133
Pedro Giavina-BianchiClinical Immunology and Allergy Division, Faculdade de Medicina da 28133Universidade de São Paulo, São Paulo, Brazil.
José Ângelo RizzoHead Pneumology Department, Hospital das Clínicas, 28111Universidade Federal de Pernambuco, Recife, Brazil.
Adelmir Souza-MachadoInstitute of Health Sciences, 28111Federal University of Bahia Coordinator of Program for Asthma Control in Bahia (ProAR), Federal University of Bahia, Salvador, Bahia, Brazil.ORCID 0000-0002-1475-2663
Guilherme Freire GarciaClinical Guidelines Coordinator of the 186064Fundação Hospitalar de Minas Gerais (FHEMIG), Belo Horizonte, Brazil.
Marcia Margaret Menezes Pizzichini28117Federal University of Santa Catarina, Florianopolis, Brazil.
Fundação Hospitalar do Estado de Minas Gerais · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRHospital das Clínicas da Universidade Federal de Pernambuco · BRHospital Moinhos de Vento · BRUniversidade Federal da Bahia · BRUniversidade Federal de Santa Catarina · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, Brazil lacks a national asthma management program and is burdened with nearly 200,000 hospitalizations due to the disease per year and approximately 5 deaths per day. The purpose of this article was to analyze the current issues surrounding severe asthma in Brazil, as the status of diagnosis and treatment is largely unknown, and to provide feasible recommendations to elicit imminent action. A panel of Brazilian medical experts in the field of severe asthma was provided with a series of relevant questions to address prior to a multi-day conference. Within this conference, each narrative was discussed and edited by the entire group. Through numerous rounds of discussion consensus was achieved. In order to overcome barriers to adequate asthma treatment, this panel recommends specific initiatives that can be implemented in the short-term to decrease the burden of severe asthma in Brazil. With increasing healthcare costs and limited resources globally, there is an opportunity to implement these recommendations in other countries in order to achieve adequate asthma care. Severe asthma is a heterogeneous and complex disease with various phenotypes that requires strict attention for diagnosis and management. Although this disease affects only a small proportion of the population with asthma, it poses a great burden to healthcare systems. Thus, barriers to diagnosis, treatment, and management should be overcome as quickly and efficiently as possible.

Indexed as

AsthmaBrazilConsensusHospitalizationHumansBrazilinnovative therapiespublic health systemSevere asthma

Identifiers

PMID34167379
PMCPMC8236765
OpenAlexW3173147836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.